“R&D outsourcing has become a ‘must have' than ‘good-to have' strategy”
Bio Spectrum|September 2021
Aragen Life Sciences (formerly GVK BIO), a leading contract research and development organisation headquartered in Hyderabad, is marking its transition to a new brand identity in its 20th year. Established in 2001, the company is poised for growth in the outsourced discovery, development, and manufacturing services sector across both large and small molecule platforms with new investments and collaborations. In conversation with BioSpectrum, Manni Kantipudi, Chief Executive Officer, Aragen Life Sciences, Hyderabad reveals more about the company’s recent rebranding and growth plans. Edited excerpts;
Sanjiv Das

GVK Bio is now known as Aragen. How is the name change going to have an impact on the brand?

The re-branding exercise has given us an opportunity to re-discover ourselves as an organisation and build upon it. The company has grown from strength to strength over the last 20 years. While our values remain the same, it is now aligned to the new brand promise and purpose, something that is imbibed by each and every employee of the organisation. This rebranding initiative enabled us to streamline and bring in a clear focus to our vision for success. Aragen is a name known for its scientific expertise and customer-centric culture in the West. We are now investing in branding around the name – our initial feedback from both current and prospective customers has been very positive. They love our new identity and our renewed purpose and promise. The number of positive responses in the social media from all our internal and external stakeholders is a testimony to the liking of our new identity. This new brand identity is well poised to launch Aragen into this exciting future.

What are the plans in store following the recent investment by Goldman Sachs?

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM BIO SPECTRUMView All

How Tech Innovations Impact Cardiac Care

Cardiac care has seen a transformation over the years with technology playing an important role. Armed with Artificial intelligence (AI) and machine learning (ML), cardiac care providers, with the right technology, have received the right impetus to revolutionise treatment mechanisms. Let us delve into the new technologies which the industry is offering to mankind and decipher the way forward.

6 mins read
Bio Spectrum
September 2021

Mynvax Offers ‘Warm Vaccine' For COVID-19

Biotech startup Mynvax, incubated at the Indian Institute of Science (IISc) in Bengaluru, has developed heat-tolerant COVID-19 vaccine formulations.

1 min read
Bio Spectrum
September 2021

“R&D outsourcing has become a ‘must have' than ‘good-to have' strategy”

Aragen Life Sciences (formerly GVK BIO), a leading contract research and development organisation headquartered in Hyderabad, is marking its transition to a new brand identity in its 20th year. Established in 2001, the company is poised for growth in the outsourced discovery, development, and manufacturing services sector across both large and small molecule platforms with new investments and collaborations. In conversation with BioSpectrum, Manni Kantipudi, Chief Executive Officer, Aragen Life Sciences, Hyderabad reveals more about the company’s recent rebranding and growth plans. Edited excerpts;

4 mins read
Bio Spectrum
September 2021

Premas Biotech to commercialise VLP vaccine tech against Delta variant

Gurugram-based Premas Biotech has signed a licensing deal with Oravax Medical for the development and commercialisation of its virus-like-particle COVID-19 vaccine technology.

1 min read
Bio Spectrum
September 2021

SARS-CoV-2: A Biochemical Treatise on its Past, Present & Future

The SARS-CoV-2 pandemic is unprecedented but equally unprecedented is the contribution of scientists who have helped us in understanding the mechanisms by which it infects human beings and also, developing a variety of vaccines to protect the masses, in a year’s time, which can be called truly groundbreaking. This article gives an overview of the progress made by scientists around the world working round the clock in developing an understanding of the SARS-CoV-2 evolution and COVID-19 disease pathogenesis, and also makes an attempt to suggest the possible ways of coping with this pandemic if we have to co-exist with it forever!

4 mins read
Bio Spectrum
September 2021

Merck launches Pergoveris Pen for fertility treatment in India

Merck Specialties, the healthcare business of Merck in India, has launched Pergoveris Pen for advanced infertility treatment in India.

1 min read
Bio Spectrum
September 2021

GUNG-HO PHARMA R&D INVESTMENTS SURPASS $3B

While the pharmaceutical industry helped combat COVID-19, from R&D actions on potential treatment strategies to balancing the medicines supply chain in the time of crisis, it struggled to maintain the natural market flow. As a result, many pharma companies had to abort some of their ongoing R&D investment plans. However for FY20-21, the average R&D expenses constituted 7.2 per cent of the total revenues of the pharma companies, with Lupin, Alembic Pharma and Dr. Reddy’s spending more than others. The cumulative R&D expenditure of the leading 10 pharma companies has been around Rs 10,627 crore ($1.43 billion) in the previous fiscal. This figure eventually reaches an approximate amount of Rs 22,500 crore ($3.03 billion) after considering the cumulative expenditure by other small and medium players of the India pharma industry.

10+ mins read
Bio Spectrum
September 2021

Glenmark ties up with SaNOtize to commercialise COVID-19 nasal spray

Mumbai-based Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research & Development Corporation

1 min read
Bio Spectrum
September 2021

CEPI prioritises Rift Valley fever vax

Sep 01, Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has signed an implementing partner agreement with Integrum Scientific (US) as part of its ongoing efforts to combat Rift Valley fever (RVF)—one of its priority diseases with epidemic potential.

1 min read
Bio Spectrum
September 2021

3D printing moulds healthcare innovations

Pharmaceuticals, bio-medicine, aviation, and automobiles industries have rapidly adopted 3D printing over the years, worldwide, to develop new solutions and prototypes. It is also helping many industries, healthcare, in particular, increase productivity. Despite all its advantages, 3D printing technology is currently posing a number of challenges in the market such as initial costs, limitation to the metals and plastics used for 3D printing, lack of policy standardisation, etc.

7 mins read
Bio Spectrum
September 2021
RELATED STORIES

BELLANDUR LAKE FROTH - Debasish Ghosh

Bangalore, India, was once known for its interconnected lake systems, which provided a reliable water source. As the city grew, these lakes have encroached, and the water became polluted day by day. The largest, Bellandur Lake, now carry huge volumes of snowy froth, which block the adjacent canals.

2 mins read
Lens Magazine
October 2020

CROWNING GLORY

Bengaluru-based philanthropist Kulsum Shadab Wahab is empowering acid attack survivors with her award-winning headgear brand, Ara Lumiere.

2 mins read
Harper's Bazaar India
September 2021

SHUTTING DOWN STUNTS

Bengaluru is going all out to thwart bikers from racing and performing wheelies on public roads

4 mins read
THE WEEK
October 24, 2021

Karnataka CM takes U-turn on ‘moral policing'

CHIEF Minister Basavaraj Bommai, who had said his government will deal with ‘moral policing’ with an iron hand following an incident in Bengaluru a month ago, did a volte-face in Mangaluru on Wednesday saying, “Action and reaction are bound to happen when there is no morality in society.”

1 min read
The New Indian Express Chennai
October 14, 2021

“Always Let People Do Their Job”

“It’s hard to let go when you are still young. We managed to do really well in hiring the first core team, and that is the most critical part of our story.”

6 mins read
Fortune India
October 2021

Rasode me kaun tha? Robot chef

The pandemic has led to an uptick in sales of kitchen gadgets. Now, a bunch of startups are trying to persuade restaurants and home cooks to embrace automation

4 mins read
The Times of India Mumbai
October 03, 2021

RPF women's team seizes crystal meth worth ₹3.2 cr

IN one of the biggest drug busts made in the country inside railway premises, an all-women team of the Railway Protection Force (RPF) on Friday seized 640 grams of the recreational drug, crystal Methamphetamine, worth nearly ₹3.2 crore from a train passenger.

1 min read
The New Indian Express Chennai
October 03, 2021

Let your kids get bored to nurture their creativity

It’s not uncommon these days to‘structure’ your children’s free time.

3 mins read
The Times of India Mumbai
October 01, 2021

44% millennials skipped breakfast amid pandemic

A recent study has shown that 44 per cent of urban millennials skipped breakfast in times of COVID and delayed meals due to increased household chores and late start to the day.

1 min read
The Times of India Mumbai
October 01, 2021

इंडिगो को महंगे तेल से लगेगा झटका

इंटरग्लोब एविएशन (इंडिगो) का शेयर बीएसई पर सोमवार के कारोबार में 2.76 प्रतिशत गिरकर 2,080 रुपये पर आ गया था, क्योंकि तेल कीमतों में तेजी और विमानन उद्योग में अधिक आपूर्ति की स्थिति से बाजार की चिंता बढ़ी है।

1 min read
Business Standard - Hindi
September 30, 2021